Protein Sciences To Begin Selling Novel Flu Vaccine; Flublok Has Virus-Free Appeal

The trivalent vaccine can be produced much faster than traditional vaccines and could be modified to compete with quadrivalent formulations.

Protein Sciences Corp. finally got FDA approval of its recombinant flu vaccine Flublok and hopes to release 150,000 doses for the current flu season by the end of the month.

Flublok is the first trivalent flu vaccine that is produced without eggs or live influenza virus. As a result, Protein...

More from Approvals

More from Product Reviews